HALO Halozyme Therapeutics, Inc. - Common Stock
حول Halozyme Therapeutics, Inc. - Common Stock نظرة عامة على الشركة من ويكيبيديا
HALO لقطة سريعة للسهم السعر، القيمة السوقية، مكرر الربحية (P/E)، ربحية السهم (EPS)، العائد على حقوق الملكية (ROE)، نسبة الدين إلى حقوق الملكية، نطاق 52 أسبوعًا
HALO مخطط سعر السهم OHLCV يومي مع مؤشرات فنية — تحريك وتكبير وتخصيص عرضك
أداء 10 سنوات اتجاهات الإيرادات وصافي الدخل والهوامش وربحية السهم
التقييم نسب مكرر الربحية (P/E)، مكرر المبيعات (P/S)، مكرر القيمة الدفترية (P/B)، EV/EBITDA — هل السهم مرتفع السعر أم رخيص؟
الربحية هامش الربح الإجمالي والتشغيلي والصافي؛ العائد على حقوق الملكية (ROE)، العائد على الأصول (ROA)، العائد على رأس المال المستثمر (ROIC)
الصحة المالية الديون، السيولة، الملاءة المالية — قوة الميزانية العمومية
النمو نمو الإيرادات وربحية السهم وصافي الدخل: مقارنة بالعام السابق (YoY)، متوسط النمو السنوي المركب لـ 3 سنوات (3Y CAGR)، متوسط النمو السنوي المركب لـ 5 سنوات (5Y CAGR)
كفاءة رأس المال معدل دوران الأصول، معدل دوران المخزون، معدل دوران المستحقات
HALO توافق الآراء التحليلي آراء المحللين الصعودية والهبوطية، السعر المستهدف لمدة 12 شهرًا، الصعود
- شراء قوي 2 12,5%
- شراء 10 62,5%
- احتفاظ 4 25,0%
- بيع 0 0,0%
- بيع قوي 0 0,0%
السعر المستهدف لمدة 12 شهرًا
9 محللين · 2026-08-14سجل الأرباح ربحية السهم الفعلية مقابل التقديرات، نسبة المفاجأة %، معدل التجاوز، تاريخ الأرباح التالي
| الفترة | EPS Actual | EPS المتوقع | المفاجأة |
|---|---|---|---|
| 30 يونيو، 2026 | $2.28 | $1.87 | 0.41% |
| 31 مارس، 2026 | $1.60 | $1.56 | 0.04% |
| 31 ديسمبر، 2025 | $-0.24 | $2.24 | -2.5% |
| 30 سبتمبر، 2025 | $1.72 | $1.66 | 0.06% |
| 30 يونيو، 2025 | $1.54 | $1.29 | 0.25% |
| 31 مارس، 2025 | $1.11 | $0.97 | 0.14% |
مقارنة الأقران (الصناعة الفرعية GICS) المقاييس الرئيسية مقابل أقران القطاع
| الرمز | القيمة السوقية | P/E | الإيرادات سنويًا | هامش الربح الصافي | ROE | هامش الربح الإجمالي |
|---|---|---|---|---|---|---|
| HALO | $7.93B | 26.3 | 37.5% | 22.7% | 166.1% | — |
| NBIX | $14.20B | 30.4 | 21.4% | 16.7% | 16.1% | — |
| BMRN | $11.43B | 33.0 | 12.9% | 10.8% | 5.8% | — |
| EXEL | $11.44B | 15.7 | 7.0% | 33.7% | 37.3% | — |
| ARWR | $4.68B | -3449.0 | 23258.2% | -0.20% | -0.50% | — |
| MDGL | $13.30B | -45.3 | 432.1% | -30.1% | -44.4% | — |
| CYTK | $7.81B | -9.7 | 376.6% | -891.6% | 152.7% | — |
| PRAX | $7.43B | -21.9 | 249.5% | — | -47.3% | — |
| SMMT | $13.56B | -12.1 | — | — | -235.1% | — |
| PTGX | $5.47B | -42.6 | -89.4% | -282.8% | -20.3% | — |
| KYMR | $6.33B | -21.1 | -16.7% | -794.0% | -24.4% | — |
الأساسيات الكاملة جميع المقاييس حسب السنة — قائمة الدخل، الميزانية العمومية، التدفق النقدي
قائمة الدخل 16
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.40B | $1.02B | $829M | $660M | $443M | $268M | $196M | $152M | $317M | $147M | $135M | $75M | |
| Cost of Revenue | $229M | $159M | $192M | $139M | $81M | $43M | $46M | $10M | $31M | $33M | $29M | $23M | |
| R&D Expense | · | $79M | $76M | $67M | $36M | $34M | $141M | $150M | $151M | $151M | $93M | $80M | |
| SG&A Expense | $207M | $154M | $149M | $144M | $50M | $46M | $77M | $61M | $54M | $46M | $40M | $36M | |
| Operating Expenses | $928M | $464M | $492M | $393M | $167M | $123M | $264M | · | · | $230M | $163M | $138M | |
| Operating Income | $469M | $551M | $338M | $268M | $276M | $144M | $-68M | $-69M | $81M | $-83M | $-27M | $-63M | |
| Interest Expense | · | · | $19M | $17M | $8M | $20M | $12M | $18M | $22M | $20M | $5M | $6M | |
| Other Non-op | $21M | $24M | $16M | $1M | $1M | $5M | $7M | $8M | $3M | $1M | $422.0K | · | |
| Pretax Income | $467M | $557M | $348M | $249M | $249M | $129M | $-72M | $-80M | $62M | $-102M | $-32M | $-68M | |
| Income Tax | $150M | $113M | $67M | $47M | $-154M | $217.0K | $-11.0K | $537.0K | $-1M | $1M | $0 | $0 | |
| Net Income | $317M | $444M | $282M | $202M | $403M | $129M | $-72M | $-80M | $63M | $-103M | $-32M | $-68M | |
| EPS (Basic) | $2.64 | $3.50 | $2.13 | $1.48 | $2.86 | $0.95 | $-0.50 | $-0.56 | $0.46 | $-0.81 | $-0.25 | · | |
| EPS (Diluted) | $2.56 | $3.43 | $2.10 | $1.44 | $2.74 | $0.91 | $-0.50 | $-0.56 | $0.45 | $-0.81 | $-0.25 | · | |
| Shares (Basic) | 119,840,000 | 126,827,000 | 131,927,000 | 136,844,000 | 140,646,000 | 136,206,000 | 144,329,000 | 143,599,000 | 136,419,000 | 127,964,000 | 126,704,000 | · | |
| Shares (Diluted) | 123,904,000 | 129,424,000 | 134,197,000 | 140,608,000 | 146,796,000 | 141,463,000 | 144,329,000 | 143,599,000 | 139,068,000 | 127,964,000 | 126,704,000 | · | |
| EBITDA | $480M | $562M | $349M | $274M | $279M | $148M | $-64M | $-67M | $83M | $-81M | $-26M | $-61M |
الميزانية العمومية 26
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $134M | $116M | $118M | $234M | $119M | $148M | $120M | $58M | $169M | $67M | $43M | $61M | |
| Short-term Investments | · | · | · | · | · | · | $301M | $297M | $300M | $138M | $65M | $74M | |
| Receivables | $426M | $288M | $233M | $187M | $91M | $98M | $59M | $30M | $22M | $16M | $32M | $9M | |
| Inventory | $176M | $142M | $128M | $100M | $54M | $61M | $29M | $23M | $5M | $15M | $9M | $6M | |
| Prepaid Expense | $65M | $39M | $49M | $45M | $40M | $28M | $33M | $21M | $14M | $21M | $22M | $10M | |
| Current Assets | $825M | $1.09B | $746M | $739M | $926M | $555M | $543M | $428M | $510M | $257M | $172M | $161M | |
| PP&E (Net) | $44M | $41M | $38M | $35M | $7M | $7M | $11M | $7M | $4M | $4M | $4M | $3M | |
| PP&E (Gross) | $78M | $66M | $58M | $50M | $20M | $19M | $18M | $24M | $17M | $16M | $14M | $12M | |
| Accum. Depreciation | $33M | $25M | $20M | $15M | $13M | $12M | · | $16M | $14M | $12M | $10M | $9M | |
| Goodwill | $580M | $417M | $417M | $409M | $0 | · | · | · | · | · | · | · | |
| Intangibles | $981M | $402M | $473M | $547M | $0 | · | · | · | · | · | · | · | |
| Total Assets | $2.53B | $2.06B | $1.73B | $1.84B | $1.10B | $580M | $566M | $440M | $520M | $262M | $182M | $166M | |
| Accounts Payable | $21M | $10M | $12M | $18M | $2M | $2M | $6M | $4M | $8M | $4M | $4M | $3M | |
| Accrued Liabilities | $156M | $129M | $101M | $100M | $24M | $20M | $56M | $50M | $40M | $29M | $27M | $14M | |
| Current Liabilities | $177M | $139M | $112M | $131M | $117M | $421M | $86M | $149M | $131M | $55M | $62M | $24M | |
| Deferred Tax | $43M | $0 | $0 | · | $0 | · | $16M | $858.0K | $173.0K | $340.0K | $380.0K | $194.0K | |
| Other Non-current Liabilities | $114M | $55M | $38M | $33M | $544.0K | $3M | $4M | $2M | $814.0K | $358.0K | $4M | $3M | |
| Total Liabilities | $2.48B | $1.70B | $1.65B | $1.67B | · | · | · | · | · | · | · | · | |
| Long-term Debt | $2.14B | $1.51B | $1.50B | $1.51B | $787M | $0 | $383M | $35M | $125M | $199M | $28M | $50M | |
| Total Debt | $2.14B | $1.51B | $1.50B | $1.51B | $877M | $397M | $403M | $126M | $202M | $217M | $50M | $50M | |
| Common Stock | $118.0K | $123.0K | $127.0K | $135.0K | $138.0K | $135.0K | $137.0K | $145.0K | $143.0K | $130.0K | $128.0K | $126.0K | |
| Retained Earnings | $55M | $360M | $91M | $143M | $-59M | $-475M | $-604M | $-531M | $-522M | $-585M | $-483M | $-450M | |
| AOCI | $-18M | $4M | $-9M | $-922.0K | $-620.0K | $22.0K | $240.0K | $-277.0K | $-450.0K | $-6.0K | $-99.0K | $-41.0K | |
| Stockholders' Equity | $49M | $364M | $84M | $170M | $197M | $151M | $92M | $249M | $208M | $-32M | $43M | $41M | |
| Liabilities + Equity | $2.53B | $2.06B | $1.73B | $1.84B | $1.10B | $580M | $566M | $440M | $520M | $262M | $182M | $166M | |
| Shares Outstanding | 117,782,000 | 123,138,000 | 126,770,000 | 135,154,000 | 137,498,000 | 135,030,000 | 136,712,580 | 144,725,164 | 142,789,000 | 129,502,000 | 128,152,000 | 125,721,000 |
التدفق النقدي 15
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $11M | $10M | $11M | $6M | $3M | $3M | $4M | $2M | $2M | $2M | $2M | $2M | |
| Stock-based Comp | $52M | $43M | $37M | $24M | $21M | $17M | $35M | $36M | $31M | $26M | $21M | $15M | |
| Amort. of Intangibles | $77M | $71M | $74M | $43M | $0 | $0 | · | · | · | · | · | · | |
| Other Non-cash | $272M | $-19M | $59M | $7M | $-127M | $-94M | $-52M | $-7M | $38M | $25M | $-27M | $4M | |
| Operating Cash Flow | $652M | $479M | $389M | $240M | $299M | $55M | $-85M | $-50M | $134M | $-50M | $-37M | $-48M | |
| CapEx | $7M | $11M | $15M | $5M | $1M | $3M | $4M | $5M | $1M | $3M | $2M | $1M | |
| Investing Cash Flow | $-546M | $-263M | $-97M | $-487M | $-406M | $78M | $-6M | $2M | $-164M | $-77M | $6M | $-33M | |
| Stock Issued | · | · | · | · | · | · | $0 | $0 | $135M | $0 | $0 | $108M | |
| Stock Repurchased | $342M | $250M | $402M | $200M | $350M | $150M | $200M | $0 | $0 | · | · | · | |
| Net Stock Activity | $-342M | $-250M | $-402M | $-200M | $-350M | $-150M | $-200M | $0 | $135M | $0 | $0 | $108M | |
| Financing Cash Flow | $-85M | $-219M | $-408M | $362M | $78M | $-106M | $153M | $-64M | $132M | $151M | $13M | $115M | |
| Net Change in Cash | $21M | $-3M | $-116M | $115M | $-29M | $28M | $62M | $-111M | $102M | $23M | $-18M | $34M | |
| Taxes Paid | $135M | $81M | $32M | $16M | $-375.0K | $180.0K | · | · | · | · | · | · | |
| Free Cash Flow | $645M | $468M | $373M | $235M | $298M | $53M | $-89M | $-54M | $133M | $-54M | $-39M | $-49M | |
| Levered FCF | · | · | $358M | $222M | $286M | $33M | $-101M | $-72M | $110M | $-74M | · | · |
الربحية 7
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 33.6% | 54.3% | 40.7% | 40.5% | 62.2% | · | · | -45.6% | 25.6% | -56.7% | -20.3% | -83.7% | |
| Net Margin | 22.7% | 43.7% | 34.0% | 30.6% | 90.8% | · | · | -52.9% | 19.9% | -70.2% | -23.9% | -90.8% | |
| Pretax Margin | 33.4% | 54.9% | 42.0% | 37.7% | 56.1% | · | · | -52.5% | 19.5% | -69.4% | · | · | |
| EBITDA Margin | 34.4% | 55.3% | 42.0% | 41.5% | 62.9% | · | · | -44.1% | 26.3% | -55.1% | -19.1% | -81.3% | |
| ROA | 13.8% | 23.4% | 15.8% | 13.7% | 47.8% | 22.5% | -14.4% | -16.7% | 16.1% | -46.5% | -18.5% | -51.1% | |
| ROE | 166.1% | 108.8% | 169.1% | 151.5% | 168.3% | 103.2% | -42.9% | -32.9% | 71.6% | -1959.0% | -76.4% | -640.2% | |
| ROIC | 14.5% | 23.5% | 17.2% | 13.0% | 41.6% | 26.3% | -13.7% | -18.6% | 20.2% | -45.7% | · | · |
السيولة والملاءة 5
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.7 | 7.8 | 6.6 | 5.7 | 7.9 | 1.3 | 6.3 | 2.9 | 3.9 | 4.7 | 2.8 | 6.6 | |
| Quick Ratio | 3.2 | 2.9 | 1.1 | 3.6 | 1.8 | 0.6 | 5.6 | 2.6 | 3.7 | 4.0 | 2.3 | 6.0 | |
| Debt / Equity | 43.9 | 4.1 | 17.9 | 8.9 | 4.5 | 2.6 | 4.4 | 0.5 | 1.0 | -6.7 | 1.2 | 1.2 | |
| LT Debt / Equity | 43.9 | 4.1 | 17.9 | 8.8 | 4.0 | 0.0 | 4.2 | 0.1 | 0.6 | -6.1 | 0.7 | 1.2 | |
| Interest Coverage | · | · | 18.0 | 15.8 | 36.7 | 7.1 | -5.8 | -3.8 | 3.7 | -4.2 | -5.3 | -11.3 |
الكفاءة 3
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.6 | 0.5 | 0.5 | 0.4 | 0.5 | · | · | 0.3 | 0.8 | 0.7 | 0.8 | 0.6 | |
| Inventory Turnover | 1.4 | 1.2 | 1.7 | 1.8 | 1.4 | 1.0 | 1.8 | 0.7 | 3.2 | 2.8 | 3.7 | 3.6 | |
| Receivables Turnover | 3.9 | 3.9 | · | 4.1 | 4.7 | · | · | 5.8 | 16.7 | 6.1 | 6.5 | 8.3 |
معدلات النمو 9
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 37.5% | 22.4% | 25.6% | 48.9% | 65.7% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 28.4% | 31.8% | 45.8% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 39.2% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | -25.4% | 63.3% | 45.8% | -47.4% | 201.1% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | 21.1% | 7.8% | 32.1% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 23.0% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | -28.6% | 57.7% | 39.3% | -49.8% | 212.0% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | 16.2% | 3.3% | 29.7% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | 19.7% | · | · | · | · | · | · | · | · | · | · | · |
التقييم (آخر 12 شهرًا) 14
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1.40B | $1.02B | $829M | $660M | $443M | $268M | $196M | $152M | $317M | $147M | $135M | $75M | |
| Net Income TTM | $317M | $444M | $282M | $202M | $403M | $129M | $-72M | $-80M | $63M | $-103M | $-32M | $-68M | |
| Market Cap | $7.93B | $5.89B | $4.69B | $7.69B | $5.53B | $5.77B | $2.42B | $2.09B | $2.89B | $1.28B | $2.22B | $1.21B | |
| Enterprise Value | $9.94B | $7.28B | $6.07B | $8.96B | $6.29B | $6.02B | $2.41B | $1.86B | $2.63B | $1.29B | $2.16B | $1.13B | |
| P/E | 26.3 | 13.9 | 17.6 | 39.5 | 14.7 | 46.9 | -35.5 | -26.1 | 45.0 | -12.2 | -69.3 | · | |
| P/S | 5.7 | 5.8 | 5.7 | 11.6 | 12.5 | 21.6 | 12.4 | 13.8 | 9.1 | 8.7 | 16.4 | 16.1 | |
| P/B | 162.4 | 16.2 | 55.9 | 45.3 | 28.1 | 38.2 | 26.4 | 8.4 | 13.9 | -39.4 | 51.6 | 29.3 | |
| P / Tangible Book | · | · | · | · | 28.1 | 38.2 | · | · | · | · | · | · | |
| P / Cash Flow | 12.2 | 12.3 | 12.1 | 32.0 | 18.5 | 104.0 | -28.4 | -42.2 | 21.6 | -25.4 | -59.9 | -25.5 | |
| P / FCF | 12.3 | 12.6 | 12.6 | 32.7 | 18.6 | 108.9 | -27.1 | -38.6 | 21.8 | -23.9 | -56.3 | -24.8 | |
| EV / EBITDA | 20.7 | 13.0 | 17.4 | 32.7 | 22.5 | 40.8 | -37.9 | -27.8 | 31.6 | -16.0 | -83.9 | -18.4 | |
| EV / FCF | 15.4 | 15.5 | 16.3 | 38.1 | 21.1 | 113.6 | -26.9 | -34.4 | 19.8 | -24.1 | -54.8 | -23.1 | |
| EV / Revenue | 7.1 | 7.2 | 7.3 | 13.6 | 14.2 | 22.5 | 12.3 | 12.3 | 8.3 | 8.8 | 16.0 | 15.0 | |
| Earnings Yield | 3.8% | 7.2% | 5.7% | 2.5% | 6.8% | 2.1% | -2.8% | -3.8% | 2.2% | -8.2% | -1.4% | · |
قائمة الدخل 16
| المقياس | اتجاه | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $481M | $377M | $452M | $354M | $326M | $265M | $298M | $290M | $231M | $196M | $230M | $216M | $221M | $162M | $181M | $209M | |
| Cost of Revenue | $79M | $79M | $79M | $55M | $46M | $48M | $42M | $49M | $40M | $28M | $52M | $55M | $50M | $35M | $42M | $47M | |
| R&D Expense | $28M | $26M | · | $17M | $18M | $15M | · | $18M | $21M | $19M | · | $17M | $20M | $18M | $23M | $17M | |
| SG&A Expense | $57M | $58M | $77M | $46M | $42M | $42M | $42M | $41M | $36M | $35M | $38M | $35M | $39M | $37M | $38M | $34M | |
| Operating Expenses | $193M | $192M | $545M | $136M | $123M | $123M | $123M | $127M | $114M | $100M | $129M | $128M | $127M | $108M | $107M | $126M | |
| Operating Income | $288M | $185M | $-93M | $218M | $202M | $142M | $176M | $163M | $117M | $96M | $101M | $88M | $94M | $54M | $75M | $83M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $5M | · | $5M | $4M | $5M | · | $8M | |
| Other Non-op | $3M | $1M | $2M | $5M | $7M | $7M | $7M | $6M | $5M | $5M | $5M | $5M | $3M | $3M | $852.0K | $641.0K | |
| Pretax Income | $285M | $180M | $-101M | $219M | $205M | $144M | $178M | $165M | $118M | $96M | $101M | $102M | $93M | $52M | $71M | $74M | |
| Income Tax | $55M | $30M | $41M | $44M | $40M | $26M | $41M | $28M | $24M | $19M | $16M | $20M | $18M | $13M | $13M | $12M | |
| Net Income | $230M | $150M | $-142M | $175M | $165M | $118M | $137M | $137M | $93M | $77M | $85M | $82M | $75M | $40M | $58M | $62M | |
| EPS (Basic) | $1.96 | $1.27 | $-1.17 | $1.49 | $1.36 | $0.96 | $1.08 | $1.08 | $0.73 | $0.61 | $0.65 | $0.62 | $0.57 | $0.29 | $0.43 | $0.45 | |
| EPS (Diluted) | $1.90 | $1.22 | $-1.13 | $1.43 | $1.33 | $0.93 | $1.06 | $1.05 | $0.72 | $0.60 | $0.64 | $0.61 | $0.56 | $0.29 | $0.41 | $0.44 | |
| Shares (Basic) | 117,274,000 | 118,144,000 | -241,937,000 | 117,219,000 | 121,343,000 | 123,215,000 | -254,080,000 | 126,850,000 | 127,116,000 | 126,941,000 | -266,795,000 | 131,965,000 | 131,730,000 | 135,027,000 | -275,278,000 | 136,527,000 | |
| Shares (Diluted) | 121,215,000 | 122,875,000 | -249,229,000 | 122,331,000 | 124,158,000 | 126,644,000 | -258,819,000 | 130,134,000 | 129,222,000 | 128,887,000 | -271,329,000 | 134,083,000 | 133,543,000 | 137,900,000 | -282,272,000 | 139,387,000 | |
| EBITDA | $292M | $189M | · | $221M | $205M | $144M | · | $166M | $120M | $98M | · | $91M | $97M | $56M | · | $85M |
الميزانية العمومية 25
| المقياس | اتجاه | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $163M | $310M | $134M | $420M | $62M | $176M | $116M | $154M | $188M | $165M | $118M | $274M | $221M | $96M | · | $147M | |
| Receivables | $453M | $458M | $426M | $344M | $315M | $304M | $288M | $273M | $210M | $185M | · | $214M | $222M | $195M | · | $233M | |
| Inventory | $137M | $155M | $176M | $186M | $182M | $165M | $142M | $131M | $159M | $169M | · | $129M | $132M | $108M | · | $103M | |
| Prepaid Expense | $109M | $71M | $65M | $95M | $77M | $45M | $39M | $44M | $85M | $46M | · | $49M | $39M | $37M | · | $51M | |
| Current Assets | $933M | $1.00B | $825M | $1.33B | $1.12B | $1.26B | $1.09B | $1.13B | $988M | $874M | · | $879M | $766M | $615M | · | $653M | |
| PP&E (Net) | $50M | $47M | $44M | $41M | $40M | $40M | $41M | $40M | $40M | $42M | · | $37M | $36M | $39M | · | $31M | |
| PP&E (Gross) | $84M | $82M | $78M | $72M | $69M | $67M | $66M | $64M | $62M | $63M | · | $56M | $53M | $55M | · | $46M | |
| Accum. Depreciation | $34M | $35M | $33M | $31M | $29M | $27M | $25M | $24M | $22M | $21M | · | $18M | $17M | $16M | · | $15M | |
| Goodwill | $582M | $582M | $580M | $417M | $417M | $417M | $417M | $417M | $417M | $417M | · | $417M | $417M | $416M | · | $199M | |
| Intangibles | $922M | $952M | $981M | $349M | $366M | $384M | $402M | $420M | $437M | $455M | · | $491M | $511M | $529M | · | $949M | |
| Total Assets | $2.58B | $2.67B | $2.53B | $2.22B | $2.05B | $2.20B | $2.06B | $2.12B | $1.97B | $1.84B | · | $1.89B | $1.81B | $1.70B | · | $1.86B | |
| Accounts Payable | $24M | $14M | $21M | $15M | $19M | $20M | $10M | $12M | $15M | $13M | · | $19M | $10M | $9M | · | $18M | |
| Accrued Liabilities | $112M | $140M | $156M | $111M | $116M | $130M | $129M | $96M | $118M | $118M | · | $95M | $105M | $80M | · | $74M | |
| Current Liabilities | $344M | $363M | $177M | $837M | $134M | $150M | $139M | $109M | $133M | $132M | · | $115M | $116M | $92M | · | $109M | |
| Deferred Tax | $49M | $48M | $43M | $8M | · | · | $0 | $12M | $14M | · | · | · | · | · | · | $29M | |
| Other Non-current Liabilities | $103M | $106M | $114M | $72M | $78M | $56M | $55M | $40M | $31M | $31M | · | $28M | $31M | $30M | · | $5M | |
| Total Liabilities | $2.43B | $2.45B | $2.48B | $1.72B | $1.72B | $1.71B | $1.70B | $1.67B | $1.68B | $1.66B | · | $1.64B | $1.66B | $1.63B | · | · | |
| Long-term Debt | $2.15B | $2.14B | $2.14B | $1.51B | $1.51B | $1.51B | $1.51B | $1.50B | $1.50B | $1.50B | · | $1.50B | $1.50B | $1.49B | · | $1.50B | |
| Total Debt | $2.15B | $2.14B | · | $1.51B | $1.51B | $1.51B | · | $1.50B | $1.50B | $1.50B | · | $1.50B | $1.50B | $1.49B | · | $1.50B | |
| Common Stock | $114.0K | $118.0K | $118.0K | $118.0K | $118.0K | $123.0K | $123.0K | $127.0K | $127.0K | $127.0K | · | $132.0K | $132.0K | $132.0K | · | $135.0K | |
| Retained Earnings | $151M | $205M | $55M | $502M | $361M | $478M | $360M | $398M | $261M | $167M | · | $222M | $140M | $66M | · | $86M | |
| AOCI | $-8M | $-13M | $-18M | $-22M | $-28M | $-3M | $4M | $-7M | $-2M | $-1M | · | $1M | $-2M | $24.0K | · | $-2M | |
| Stockholders' Equity | $144M | $220M | $49M | $504M | $333M | $482M | $364M | $453M | $289M | $178M | $84M | $249M | $151M | $66M | $170M | $97M | |
| Liabilities + Equity | $2.58B | $2.67B | $2.53B | $2.22B | $2.05B | $2.20B | $2.06B | $2.12B | $1.97B | $1.84B | · | $1.89B | $1.81B | $1.70B | · | $1.86B | |
| Shares Outstanding | 114,042,000 | 118,523,000 | 117,782,000 | 117,523,000 | 117,621,000 | 123,170,000 | 123,138,000 | 127,183,000 | 126,535,000 | 127,186,000 | · | 132,081,000 | 131,856,000 | 131,662,000 | · | 135,211,000 |
التدفق النقدي 13
| المقياس | اتجاه | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $4M | $4M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $2M | $3M | $3M | $3M | $3M | $3M | $2M | |
| Stock-based Comp | $18M | $17M | $17M | $12M | $12M | $11M | $11M | $13M | $9M | $10M | $10M | $9M | $10M | $8M | $7M | $7M | |
| Amort. of Intangibles | $30M | $30M | $23M | $18M | $18M | $18M | $18M | $18M | $18M | $18M | $18M | $20M | $18M | $18M | $5M | $27M | |
| Other Non-cash | · | $9M | · | · | · | $23M | · | · | · | $40M | · | · | · | $37M | · | · | |
| Operating Cash Flow | $241M | $180M | $219M | $179M | $100M | $154M | $178M | $115M | $56M | $129M | $102M | $132M | $67M | $87M | $82M | $70M | |
| CapEx | $4M | $4M | $1M | $3M | $2M | $950.0K | $3M | $2M | $3M | $4M | $3M | $3M | $-2M | $11M | $2M | $1M | |
| Investing Cash Flow | $-63M | $-3M | $-742M | $202M | $85M | $-90M | $29M | $-167M | $-42M | $-83M | $-8M | $-83M | $55M | $-60M | $-2M | $-1M | |
| Stock Repurchased | · | · | $0 | $39M | · | · | $250M | $0 | $0 | $0 | $252M | $0 | $0 | $150M | $1.0K | $200M | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | $0 | · | · | · | $-150M | · | · | |
| Financing Cash Flow | $-326M | $-2M | $240M | $-22M | $-299M | $-3M | $-246M | $19M | $9M | $-489.0K | $-250M | $4M | $2M | $-165M | $6M | $-12M | |
| Net Change in Cash | $-148M | $176M | $-283M | $358M | $-114M | $60M | $-38M | $-34M | $23M | $46M | $-156M | $53M | $124M | $-138M | $87M | $56M | |
| Free Cash Flow | · | $176M | · | · | · | $153M | · | · | · | $126M | · | · | · | $76M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $122M | · | · | · | $72M | · | · |
الربحية 7
| المقياس | اتجاه | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 59.8% | 49.0% | · | 61.5% | 62.2% | 53.4% | · | 56.3% | 50.7% | 48.8% | · | 40.9% | 42.7% | 33.2% | · | 39.9% | |
| Net Margin | 47.8% | 39.8% | · | 49.5% | 50.7% | 44.6% | · | 47.2% | 40.3% | 39.2% | · | 37.9% | 33.8% | 24.4% | · | 29.5% | |
| Pretax Margin | 59.2% | 47.9% | · | 61.8% | 62.9% | 54.3% | · | 56.9% | 50.9% | 49.0% | · | 47.1% | 42.1% | 32.2% | · | 35.3% | |
| EBITDA Margin | 60.7% | 50.1% | · | 62.3% | 63.0% | 54.4% | · | 57.1% | 51.8% | 50.0% | · | 42.1% | 44.0% | 34.8% | · | 40.8% | |
| ROA | 9.9% | 6.2% | · | 8.1% | 8.2% | 5.9% | · | 6.8% | 4.9% | 4.3% | · | 4.4% | 4.2% | 2.8% | · | 4.0% | |
| ROE | 96.5% | 42.8% | · | 36.6% | 53.1% | 35.8% | · | 39.0% | 42.3% | 63.1% | · | 47.3% | 33.7% | 24.3% | · | 32.6% | |
| ROIC | 10.1% | 6.5% | · | 8.7% | 8.9% | 5.8% | · | 6.9% | 5.2% | 4.5% | · | 4.1% | 4.6% | 2.6% | · | 4.3% |
السيولة والملاءة 5
| المقياس | اتجاه | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.7 | 2.8 | · | 1.6 | 8.4 | 8.4 | · | 10.4 | 7.4 | 6.6 | · | 7.6 | 6.6 | 6.7 | · | 6.0 | |
| Quick Ratio | 1.8 | 2.1 | · | 0.9 | 2.8 | 3.2 | · | 3.9 | 3.0 | 2.7 | · | 4.2 | 3.8 | 3.2 | · | 3.5 | |
| Debt / Equity | 15.0 | 9.8 | · | 3.0 | 4.5 | 3.1 | · | 3.3 | 5.2 | 8.4 | · | 6.0 | 9.9 | 22.7 | · | 15.5 | |
| LT Debt / Equity | 13.5 | 8.8 | · | 1.6 | 4.5 | 3.1 | · | 3.3 | 5.2 | 8.4 | · | 6.0 | 9.9 | 22.7 | · | 15.4 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | 21.2 | · | 19.6 | 21.0 | 11.8 | · | 11.1 |
الكفاءة 3
| المقياس | اتجاه | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Inventory Turnover | 0.5 | 0.5 | · | 0.3 | 0.3 | 0.3 | · | 0.4 | 0.3 | 0.2 | · | 0.5 | 0.4 | 0.5 | · | 0.6 | |
| Receivables Turnover | 1.3 | 1.0 | · | 1.1 | 1.2 | 1.1 | · | 1.2 | 1.1 | 1.0 | · | 1.0 | 1.1 | 1.1 | · | 1.2 |
التقييم (آخر 12 شهرًا) 13
| المقياس | اتجاه | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1.54B | $1.32B | · | $1.23B | $1.11B | $982M | · | $933M | $864M | $795M | · | $808M | $745M | $676M | · | · | |
| Net Income TTM | $720M | $609M | · | $595M | $514M | $425M | · | $389M | $327M | $273M | · | $258M | $199M | $147M | · | · | |
| Market Cap | $8.93B | $7.66B | · | $8.62B | $6.12B | $7.86B | · | $7.28B | $6.63B | $5.17B | · | $5.05B | $4.76B | $5.03B | · | $5.35B | |
| Enterprise Value | $10.91B | $9.50B | · | $9.71B | $7.57B | $9.19B | · | $8.63B | $7.94B | $6.51B | · | $6.27B | $6.03B | $6.43B | · | $6.70B | |
| P/E | 13.3 | 13.2 | · | 15.5 | 12.9 | 19.3 | · | 19.2 | 21.0 | 19.7 | · | 20.1 | 24.9 | 36.4 | · | · | |
| P/S | 5.8 | 5.8 | · | 7.0 | 5.5 | 8.0 | · | 7.8 | 7.7 | 6.5 | · | 6.2 | 6.4 | 7.4 | · | · | |
| P/B | 62.2 | 34.9 | · | 17.1 | 18.4 | 16.3 | · | 16.1 | 22.9 | 29.1 | · | 20.2 | 31.5 | 76.4 | · | 55.1 | |
| P / Cash Flow | · | 42.5 | · | · | · | 51.0 | · | · | · | 40.0 | · | · | · | 57.8 | · | · | |
| P / FCF | · | 43.4 | · | · | · | 51.3 | · | · | · | 41.1 | · | · | · | 66.5 | · | · | |
| EV / EBITDA | 37.3 | 50.3 | · | 44.0 | 36.9 | 63.7 | · | 52.1 | 66.3 | 66.4 | · | 68.9 | 62.0 | 113.9 | · | 78.6 | |
| EV / FCF | · | 53.8 | · | · | · | 60.0 | · | · | · | 51.7 | · | · | · | 85.0 | · | · | |
| EV / Revenue | 7.1 | 7.2 | · | 7.9 | 6.8 | 9.4 | · | 9.2 | 9.2 | 8.2 | · | 7.8 | 8.1 | 9.5 | · | · | |
| Earnings Yield | 7.5% | 7.6% | · | 6.5% | 7.8% | 5.2% | · | 5.2% | 4.8% | 5.1% | · | 5.0% | 4.0% | 2.8% | · | · |
القوائم المالية قائمة الدخل، الميزانية العمومية، التدفقات النقدية — سنويًا، آخر 5 سنوات
قائمة الدخل
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| الإيرادات | $1.40B | $1.02B | $829M | $660M | $443M |
| هامش الربح التشغيلي % | 33.6% | 54.3% | 40.7% | 40.5% | 62.2% |
| صافي الدخل | $317M | $444M | $282M | $202M | $403M |
| EPS المخفف | $2.56 | $3.43 | $2.10 | $1.44 | $2.74 |
الميزانية العمومية
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| الدين / حقوق الملكية | 43.9 | 4.1 | 17.9 | 8.9 | 4.5 |
| النسبة الحالية | 4.7 | 7.8 | 6.6 | 5.7 | 7.9 |
| النسبة السريعة | 3.2 | 2.9 | 1.1 | 3.6 | 1.8 |
التدفق النقدي
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| التدفق النقدي الحر | $645M | $468M | $373M | $235M | $298M |
آخر الأخبار أحدث العناوين التي تذكر هذه الشركة
إشارات التداول إشارات شراء/بيع حديثة مع سعر الدخول ونسبة المخاطرة/المكافأة
مقاييسي قائمة المراقبة الشخصية الخاصة بك — صفوف مختارة من الأساسيات الكاملة
اختر المقاييس التي تهمك — انقر فوق علامة ➕ بجوار أي صف في الأساسيات الكاملة أعلاه.
يتم حفظ اختيارك ويتبعك عبر جميع الأسهم.
الملاك المؤسسيون (13F) 723 مقدمي إقرار · $5.8B إجمالي · حتى تاريخ 30 يونيو، 2026
المؤسسات التي تبلغ عن حيازتها لهذا السهم في نموذج SEC 13F ربع السنوي الخاص بها. المراكز الطويلة فقط؛ قد يظهر مقدم واحد مرتين لأرجل خيارات منفصلة. الأرجل الكبيرة المتعاكسة من خيارات البيع/الشراء تعكس عادةً صناعة السوق أو المخزون المتحوط، وليس القناعة الاتجاهية.
| مراكز جديدة | المراكز الخارجة | زيادة | انخفض | صافي التغير في الأسهم |
|---|---|---|---|---|
| 101 (-11 مقابل الربع السابق) | 62 (0 مقابل الربع السابق) | 257 (+32 مقابل الربع السابق) | 201 (-8 مقابل الربع السابق) | +11.7M |
مقارنة بـ Q1 2026. المواعيد النهائية لتقديم إقرارات نموذج 13F لهيئة الأوراق المالية والبورصات (SEC) هي في غضون 45 يومًا من نهاية الربع بالإضافة إلى فترة سماح قصيرة للمقدمين المتأخرين — يتم تخطي الأرباع التي لا تزال ضمن هذه النافذة لصالح أحدث زوج تم الإبلاغ عنه بالكامل.
| مؤسسة | القيمة | الأسهم | % من 13F المتتبعة | النوع |
|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | $418847190 | 5351312 | 7,23% | الأسهم |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $414753356 | 5299008 | 7,15% | الأسهم |
| STATE STREET CORP | $405379779 | 5179434 | 6,99% | الأسهم |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | $196539884 | 2511050 | 3,39% | الأسهم |
| SNYDER CAPITAL MANAGEMENT L P | $187542825 | 2396101 | 3,24% | الأسهم |
| GEODE CAPITAL MANAGEMENT, LLC | $161871438 | 2067539 | 2,79% | الأسهم |
| LOS ANGELES CAPITAL MANAGEMENT LLC | $151690000 | 1938035 | 2,62% | الأسهم |
| DIMENSIONAL FUND ADVISORS LP | $149867562 | 1914752 | 2,59% | الأسهم |
| BANK OF AMERICA CORP /DE/ | $141963308 | 1813764 | 2,45% | الأسهم |
| ROYAL LONDON ASSET MANAGEMENT LTD | $141732491 | 1810815 | 2,44% | الأسهم |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $133420842 | 1704623 | 2,30% | الأسهم |
| TWO SIGMA INVESTMENTS, LP | $129402617 | 1653285 | 2,23% | الأسهم |
| FULLER & THALER ASSET MANAGEMENT, INC. | $116700910 | 1491004 | 2,01% | الأسهم |
| NORGES BANK | $116125129 | 1483648 | 2,00% | الأسهم |
| FIRST TRUST ADVISORS LP | $110913469 | 1417063 | 1,91% | الأسهم |
| ALLIANCEBERNSTEIN L.P. | $109647251 | 1696538 | 1,89% | الأسهم |
| Stephens Investment Management Group LLC | $109015943 | 1392819 | 1,88% | الأسهم |
| CONGRESS ASSET MANAGEMENT CO | $96202127 | 1229106 | 1,66% | الأسهم |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $92656000 | 1183799 | 1,60% | الأسهم |
| TD Asset Management Inc | $87328187 | 1115730 | 1,51% | الأسهم |
| Caisse de depot et placement du Quebec | $83939801 | 1072439 | 1,45% | الأسهم |
| Assenagon Asset Management S.A. | $78085518 | 997643 | 1,35% | الأسهم |
| Mizuho Markets Cayman LP | $65316315 | 834500 | 1,13% | الأسهم |
| VANGUARD FIDUCIARY TRUST CO | $59930713 | 765692 | 1,03% | الأسهم |
| Gotham Asset Management, LLC | $57862898 | 739273 | 1,00% | الأسهم |
| Boston Trust Walden Corp | $49923111 | 637832 | 0,86% | الأسهم |
| KENNEDY CAPITAL MANAGEMENT LLC | $42656680 | 544994 | 0,74% | الأسهم |
| BNP PARIBAS FINANCIAL MARKETS | $41396142 | 528889 | 0,71% | الأسهم |
| VICTORY CAPITAL MANAGEMENT INC | $40477956 | 517158 | 0,70% | الأسهم |
| RENAISSANCE TECHNOLOGIES LLC | $37539153 | 479611 | 0,65% | الأسهم |
| Bridgewater Associates, LP | $36250437 | 463146 | 0,63% | الأسهم |
| RENAISSANCE GROUP LLC | $35005643 | 447242 | 0,60% | الأسهم |
| JANUS HENDERSON GROUP PLC | $33624985 | 520269 | 0,58% | الأسهم |
| Fisher Asset Management, LLC | $33477096 | 427713 | 0,58% | الأسهم |
| Arbejdsmarkedets Tillaegspension | $32505531 | 415300 | 0,56% | الأسهم |
| MetLife Investment Management, LLC | $31511893 | 402605 | 0,54% | الأسهم |
| MIZUHO MARKETS AMERICAS LLC | $30766450 | 393081 | 0,53% | الأسهم |
| Retirement Systems of Alabama | $27586575 | 352454 | 0,48% | الأسهم |
| FRONTIER CAPITAL MANAGEMENT CO LLC | $26812936 | 342570 | 0,46% | الأسهم |
| RHUMBLINE ADVISERS | $25886502 | 330734 | 0,45% | الأسهم |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $25232448 | 322377 | 0,44% | الأسهم |
| OBERWEIS ASSET MANAGEMENT INC/ | $25127018 | 321030 | 0,43% | الأسهم |
| SEGALL BRYANT & HAMILL, LLC | $24883911 | 317924 | 0,43% | الأسهم |
| GOLDMAN SACHS GROUP INC | $24435268 | 312192 | 0,42% | الأسهم |
| CITADEL ADVISORS LLC | $22627074 | 289090 | 0,39% | الأسهم |
| California Public Employees Retirement System | $22124737 | 282672 | 0,38% | الأسهم |
| ENVESTNET ASSET MANAGEMENT INC | $21063640 | 269115 | 0,36% | الأسهم |
| PRINCIPAL FINANCIAL GROUP INC | $20978160 | 268023 | 0,36% | الأسهم |
| NEUBERGER BERMAN GROUP LLC | $20761665 | 265257 | 0,36% | الأسهم |
| Cresset Asset Management, LLC | $20423539 | 260937 | 0,35% | الأسهم |
| AMERIPRISE FINANCIAL INC | $20048470 | 256145 | 0,35% | الأسهم |
| BARCLAYS PLC | $20036650 | 255994 | 0,35% | الأسهم |
| South Street Advisors LLC | $18682188 | 238689 | 0,32% | الأسهم |
| Swiss National Bank | $18604779 | 237700 | 0,32% | الأسهم |
| Clark Capital Management Group, Inc. | $18155197 | 231956 | 0,31% | الأسهم |
| RAYMOND JAMES FINANCIAL INC | $17432216 | 222719 | 0,30% | الأسهم |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $16010601 | 204556 | 0,28% | الأسهم |
| LPL Financial LLC | $15932385 | 203557 | 0,27% | الأسهم |
| Swedbank AB | $15838874 | 202362 | 0,27% | الأسهم |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $14832165 | 189500 | 0,26% | عقد خيار الشراء |
| Corient Private Wealth LP | $14671472 | 187447 | 0,25% | الأسهم |
| KORNITZER CAPITAL MANAGEMENT INC /KS | $14587571 | 186375 | 0,25% | الأسهم |
| Mesirow Institutional Investment Management, Inc. | $14445696 | 302148 | 0,25% | الأسهم |
| SCHRODER INVESTMENT MANAGEMENT GROUP | $14032868 | 181820 | 0,24% | الأسهم |
| BlackRock, Inc. | $13794774 | 176246 | 0,24% | الأسهم |
| ASSETMARK, INC | $13645122 | 174334 | 0,24% | الأسهم |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $13623754 | 174061 | 0,24% | الأسهم |
| Quantinno Capital Management LP | $13037160 | 166566 | 0,22% | الأسهم |
| Susquehanna Portfolio Strategies, LLC | $13032190 | 166503 | 0,22% | الأسهم |
| Focus Partners Wealth | $12760854 | 163036 | 0,22% | الأسهم |
| Congress Wealth Management LLC / DE / | $12754131 | 245177 | 0,22% | الأسهم |
| INTECH INVESTMENT MANAGEMENT LLC | $12702594 | 162292 | 0,22% | الأسهم |
| Glenmede Investment Management, LP | $12666624 | 172711 | 0,22% | الأسهم |
| HARVEY CAPITAL MANAGEMENT INC | $11436265 | 146113 | 0,20% | الأسهم |
| UBS Group AG | $11319173 | 144617 | 0,20% | الأسهم |
| Future Fund LLC | $11114888 | 142007 | 0,19% | الأسهم |
| GLENMEDE TRUST CO NA | $10836090 | 138445 | 0,19% | الأسهم |
| Hudson Bay Capital Management LP | $10566450 | 135000 | 0,18% | الأسهم |
| CANADA PENSION PLAN INVESTMENT BOARD | $10378602 | 132600 | 0,18% | الأسهم |
| Hodges Capital Management Inc. | $10337197 | 132071 | 0,18% | الأسهم |
| Portolan Capital Management, LLC | $9979268 | 127498 | 0,17% | الأسهم |
| MARSHALL WACE, LLP | $9882683 | 126264 | 0,17% | الأسهم |
| CAPTRUST FINANCIAL ADVISORS | $9857805 | 125946 | 0,17% | الأسهم |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $9783750 | 125000 | 0,17% | عقد خيار البيع |
| LAZARD ASSET MANAGEMENT LLC | $9185767 | 117360 | 0,16% | الأسهم |
| Panoramic Capital, LLC | $9111880 | 116416 | 0,16% | الأسهم |
| VANGUARD ASSET MANAGEMENT, Ltd | $8892646 | 113615 | 0,15% | الأسهم |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $8812042 | 136346 | 0,15% | الأسهم |
| TWO SIGMA ADVISERS, LP | $8695160 | 129200 | 0,15% | الأسهم |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | $8565477 | 109435 | 0,15% | الأسهم |
| Steamboat Capital Partners, LLC | $8481807 | 108366 | 0,15% | الأسهم |
| Artemis Investment Management LLP | $8475389 | 108284 | 0,15% | الأسهم |
| AMERICAN CENTURY COMPANIES INC | $8423339 | 107619 | 0,15% | الأسهم |
| D. E. Shaw & Co., Inc. | $8406981 | 107410 | 0,15% | الأسهم |
| Woodline Partners LP | $8152760 | 104162 | 0,14% | الأسهم |
| CITADEL ADVISORS LLC | $7725249 | 98700 | 0,13% | عقد خيار الشراء |
| Cutter Capital Management, LP | $7657200 | 120000 | 0,13% | الأسهم |
| ArrowMark Colorado Holdings LLC | $7610192 | 97230 | 0,13% | الأسهم |
| Livforsakringsbolaget Skandia, Omsesidigt | $7503543 | 116100 | 0,13% | الأسهم |
| FIFTH THIRD BANCORP | $7488901 | 95681 | 0,13% | الأسهم |
المطلعون على الشركة 46 من المطلعين · مسؤولون 24 · مديرون 16
| مطلع | الدور | آخر نشاط | الأسهم المملوكة | مشتريات 12 شهرًا | مبيعات 12 شهرًا | صافي 12 شهرًا |
|---|---|---|---|---|---|---|
| Helen Torley | PRESIDENT AND CEO | 8 يوليو، 2026 M | 767780 | 0 | 55 | $-22823911 |
| Gregory Ian Frost | CEO, President | 12 أغسطس، 2013 M | 3591380 | 0 | 0 | $0 |
| Darren Snellgrove | SVP, Chief Financial Officer | 1 يوليو، 2026 A | — | 0 | 0 | $0 |
| Nicole Labrosse | SVP, CHIEF FINANCIAL OFFICER | 23 فبراير، 2026 M | 38494 | 0 | 0 | $0 |
| Laurie Stelzer | SVP, Chief Financial Officer | 22 فبراير، 2020 M | 116167 | 0 | 0 | $0 |
| Kurt A Gustafson | VP, Chief Financial Officer | 2 فبراير، 2012 A | — | 0 | 0 | $0 |
| Cortney Caudill | SVP, CHIEF OPERATING OFFICER | 10 مارس، 2026 M | 7055 | 0 | 4 | $-2233042 |
| Mark J Gergen | SVP, Chief Operating Officer | 22 فبراير، 2017 A | — | 0 | 0 | $0 |
| David A Ramsay | EVP, PRESIDENT, DRUG DELIVERY | 1 يوليو، 2026 A | 4592 | 0 | 0 | $0 |
| Mark Howard Snyder | SVP, CHIEF LEGAL OFFICER | 12 يونيو، 2026 M | 49929 | 0 | 0 | $0 |
| Michael J. Labarre | SVP, Chief Technical Officer | 16 فبراير، 2022 A | 173137 | 0 | 0 | $0 |
| Masaru Matsuda | SVP, General Counsel | 4 سبتمبر، 2021 M | 20049 | 0 | 0 | $0 |
| Benjamin Hickey | SVP, Chief Commerical Officer | 1 أكتوبر، 2019 M | 13226 | 0 | 0 | $0 |
| Dimitrios Chondros | SVP, Chief Medical Officer | 3 أغسطس، 2019 S | 38584 | 0 | 0 | $0 |
| Alison A. Armour | SVP, Research & Development | 3 يونيو، 2019 A | — | 0 | 0 | $0 |
| Harry J Leonhardt | SVP, GC | 13 إبريل، 2019 M | 66373 | 0 | 0 | $0 |
| Athena Countouriotis | SVP and Chief Medical Officer | 22 فبراير، 2017 A | 39077 | 0 | 0 | $0 |
| James P Shaffer | VP & Chief Commercial Officer | 6 فبراير، 2014 A | 54025 | 0 | 0 | $0 |
| Jean I Liu | VP & General Counsel | 6 فبراير، 2014 A | 20869 | 0 | 0 | $0 |
| Michael H. Shepard | VP & Chief Scientific Officer | 2 فبراير، 2012 A | — | 0 | 0 | $0 |
| William J Fallon | VP, Manufacturing & Operations | 10 مايو، 2011 A | — | 0 | 0 | $0 |
| Richard C Yocum | VP Clinical Development | 21 مارس، 2007 M | 65975 | 0 | 0 | $0 |
| Don A Kennard | Vice President, Regulatory Aff | 5 فبراير، 2007 A | 3000 | 0 | 0 | $0 |
| Carolyn Rynard | Vice President | 9 فبراير، 2005 M | 100000 | 0 | 0 | $0 |
| Mahesh Krishnan | مدير | 29 يونيو، 2026 M | 14462 | 0 | 1 | $-547800 |
| James Paul Lang | مدير | 5 مايو، 2026 A | 4685 | 0 | 0 | $0 |
| Matthew L. Posard | مدير | 5 مايو، 2026 A | 77835 | 0 | 0 | $0 |
| Barbara Gayle Duncan | مدير | 5 مايو، 2026 A | 23715 | 0 | 0 | $0 |
| Jeffrey William Henderson | مدير | 5 مايو، 2026 A | 36572 | 0 | 0 | $0 |
| Jean-Pierre Bizzari | مدير | 5 مايو، 2022 A | 58750 | 0 | 0 | $0 |
| Akiko Moni Miyashita | مدير | 5 مايو، 2022 A | 6206 | 0 | 0 | $0 |
| James M Daly | مدير | 5 مايو، 2022 A | 32438 | 0 | 0 | $0 |
| Connie Matsui | مدير | 5 مايو، 2022 A | 188189 | 0 | 0 | $0 |
| Kenneth J Kelley | مدير | 14 إبريل، 2021 S | 179833 | 0 | 0 | $0 |
| Kathryn E Falberg | مدير | 4 مايو، 2016 A | 358253 | 0 | 0 | $0 |
| John Stuart Patton | مدير | 19 أغسطس، 2014 M | 179876 | 0 | 0 | $0 |
| Robert L Engler MD | مدير | 14 أغسطس، 2014 M | 273176 | 0 | 0 | $0 |
| Steven T Thornton | مدير | 15 يونيو، 2007 M | 15000 | 0 | 0 | $0 |
| RANDAL J. KIRK | مالك 10% | 27 يوليو، 2018 S | 3616655 | 0 | 0 | $0 |
| Bernadette Connaughton | — | 10 أغسطس، 2026 S | 40418 | 0 | 8 | $-839371 |
| Elaine D Sun | — | 1 إبريل، 2021 M | 14018 | 0 | 0 | $0 |
| Jonathan E Lim | — | 5 فبراير، 2009 A | 700000 | 0 | 0 | $0 |
| Robert J Little | — | 5 فبراير، 2009 A | 4000 | 0 | 0 | $0 |
| Matthew Hooper | — | 12 نوفمبر، 2007 A | — | 0 | 0 | $0 |
| Mitch Keeler | — | 10 مارس، 2004 J | 15000 | 0 | 0 | $0 |
| Mellissa Day | — | 10 مارس، 2004 J | 999 | 0 | 0 | $0 |
المطلعون من إيداعات SEC Form 3/4/5؛ صافي = سوق مفتوح فقط
الناشطون والمالكون بنسبة 5%+ 2 حيازتان
المستثمرون الذين قدموا الجدول الزمني 13D لدى هيئة الأوراق المالية والبورصات — ملكية مستفيدة تزيد عن 5% مع نية التأثير على المُصدر (حصص الناشطين، حملات مجلس الإدارة، الاندماج والاستحواذ). يعرض كل صف أحدث حالة معروفة لمركز مقدم الطلب هذا.
| مقدم | مقدم | حصة | الحالة | الغرض | إيداع |
|---|---|---|---|---|---|
| RANDAL J. KIRK ×14 إيداعات | 5 نوفمبر، 2019 | — | إيداع أولي | — | SEC |
| شخص مُبلِّغ لم يُكشف عنه | 6 مايو، 2004 | — | إيداع أولي | اندماج واستحواذ / بيع | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ملكية صناديق المؤشرات المتداولة محتفظ بها بواسطة 122 صناديق مؤشرات متداولة
الوزن يعكس فقط ممتلكات الأسهم المباشرة (N-PORT)؛ قد تحتفظ الصناديق المضاعفة أو القائمة على المشتقات بتعرض إضافي للمقايضة غير معروض.
| صندوق | الوزن | الوحدات | حتى تاريخ | المصدر |
|---|---|---|---|---|
| PBE · Invesco Exchange-Traded Fund Trust | 3,59% | 126229 SH | 8 أغسطس، 2026 | يومي |
| SCAP · Series Portfolios Trust | 2,81% | 8596 NS | 31 مايو، 2026 | N-PORT |
| GRPM · Invesco Exchange-Traded Fund Trust | 2,70% | 133133 SH | 8 أغسطس، 2026 | يومي |
| RFG · Invesco Exchange-Traded Fund Trust | 2,46% | 85715 SH | 8 أغسطس، 2026 | يومي |
| CSMD · Professionally Managed Portfolios | 2,30% | 156567 NS | 30 إبريل، 2026 | N-PORT |
| AZTD · Tidal Trust I | 1,76% | 12120 NS | 30 إبريل، 2026 | N-PORT |
| BBP · ETFis Series Trust I | 1,63% | 15211 NS | 30 إبريل، 2026 | N-PORT |
| FFND · Northern Lights Fund Trust II | 1,39% | 21462 NS | 31 مايو، 2026 | N-PORT |
| JMID · Janus Detroit Street Trust | 1,26% | 3618 NS | 30 إبريل، 2026 | N-PORT |
| CANC · Tema ETF Trust | 1,23% | 32598 NS | 31 مايو، 2026 | N-PORT |
| SAWS · ETF Series Solutions | 1,11% | 1232 NS | 30 إبريل، 2026 | N-PORT |
| BUL · Pacer Funds Trust | 0,94% | 18816 NS | 30 إبريل، 2026 | N-PORT |
| JSMD · Janus Detroit Street Trust | 0,94% | 144590 NS | 30 إبريل، 2026 | N-PORT |
| ILDR · First Trust Exchange-Traded Fund VI… | 0,93% | 40132 NS | 31 مايو، 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,90% | 73023 NS | 30 إبريل، 2026 | N-PORT |
| ROE · EA Series Trust | 0,87% | 33876 NS | 29 مايو، 2026 | N-PORT |
| ALIL · EA Series Trust | 0,86% | 3320 NS | 29 مايو، 2026 | N-PORT |
| FXH · First Trust Exchange-Traded AlphaDE… | 0,85% | 117113 NS | 30 إبريل، 2026 | N-PORT |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,83% | 6454 SH | 8 أغسطس، 2026 | يومي |
| IBB · iShares Trust | 0,78% | 862036 SH | 8 أغسطس، 2026 | يومي |
| COWG · Pacer Funds Trust | 0,74% | 253492 NS | 30 إبريل، 2026 | N-PORT |
| AFMC · First Trust Exchange-Traded Fund VI… | 0,64% | 15633 NS | 31 مايو، 2026 | N-PORT |
| LSEQ · Harbor ETF Trust | 0,59% | 1427 NS | 30 إبريل، 2026 | N-PORT |
| MMSC · First Trust Exchange-Traded Fund VI… | 0,58% | 4569 NS | 31 مايو، 2026 | N-PORT |
| AGNG · Global X Funds | 0,56% | 6843 NS | 31 مايو، 2026 | N-PORT |
| IJK · iShares Trust | 0,54% | 693226 SH | 8 أغسطس، 2026 | يومي |
| IVOG · VANGUARD ADMIRAL FUNDS | 0,49% | 117038 SH | 8 أغسطس، 2026 | يومي |
| SMDX · Tidal Trust III | 0,46% | 9165 NS | 30 إبريل، 2026 | N-PORT |
| SIXL · EXCHANGE TRADED CONCEPTS TRUST | 0,43% | 12111 NS | 31 مايو، 2026 | N-PORT |
| NUSC · Nushares ETF Trust | 0,43% | 86197 NS | 30 إبريل، 2026 | N-PORT |
| ABOT · Abacus FCF ETF Trust | 0,41% | 282 NS | 30 إبريل، 2026 | N-PORT |
| BIB · ProShares Trust | 0,39% | 4364 NS | 31 مايو، 2026 | N-PORT |
| FNY · First Trust Exchange-Traded AlphaDE… | 0,39% | 31828 NS | 30 إبريل، 2026 | N-PORT |
| QGRO · AMERICAN CENTURY ETF TRUST | 0,38% | 125473 NS | 31 مايو، 2026 | N-PORT |
| AFSM · First Trust Exchange-Traded Fund VI… | 0,35% | 5253 NS | 31 مايو، 2026 | N-PORT |
| QVMM · Invesco Exchange-Traded Fund Trust … | 0,34% | 14758 SH | 8 أغسطس، 2026 | يومي |
| JPME · J.P. Morgan Exchange-Traded Fund Tr… | 0,34% | 23144 NS | 30 إبريل، 2026 | N-PORT |
| SMLF · iShares Trust | 0,33% | 161079 SH | 8 أغسطس، 2026 | يومي |
| XJH · iShares Trust | 0,32% | 16037 SH | 8 أغسطس، 2026 | يومي |
| ISCV · iShares Trust | 0,32% | 26095 SH | 8 أغسطس، 2026 | يومي |
| MIDE · DBX ETF Trust | 0,31% | 158 NS | 29 مايو، 2026 | N-PORT |
| IQSM · New York Life Investments ETF Trust | 0,31% | 15405 NS | 30 إبريل، 2026 | N-PORT |
| SMMV · iShares Trust | 0,30% | 10318 SH | 8 أغسطس، 2026 | يومي |
| GQQQ · EA Series Trust | 0,29% | 6432 NS | 29 مايو، 2026 | N-PORT |
| IWP · iShares Trust | 0,29% | 678051 SH | 8 أغسطس، 2026 | يومي |
| IJH · iShares Trust | 0,28% | 4092514 SH | 8 أغسطس، 2026 | يومي |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,27% | 74228 SH | 8 أغسطس، 2026 | يومي |
| VBK · VANGUARD INDEX FUNDS | 0,25% | 1570798 SH | 8 أغسطس، 2026 | يومي |
| IVOO · VANGUARD ADMIRAL FUNDS | 0,25% | 191789 SH | 8 أغسطس، 2026 | يومي |
| JPUS · J.P. Morgan Exchange-Traded Fund Tr… | 0,24% | 16701 NS | 30 إبريل، 2026 | N-PORT |